Heidrun Hildebrand is Pediatric Development Alliance Manager, Pediatric Development; 
Research and Development Pharmaceuticals at Bayer AG, Germany.

20 plus years’ experience in drug development.
Since February 2017, Heidrun is part of the Paediatric Development Group at Bayer, a new function established in 2017 and solely dedicated to Pediatric Development.

Heading Bayer’s internal Paediatric Advisory Group since 2011, providing knowledge and guidance regarding Paediatric development activities; acting as Bayer’s key contact to external stakeholders in Paediatric Development. 
Heidrun is representing Bayer in several external initiatives related to Paediatric Drug Development and is currently co-leading conect4children (c4c) an IMI2 initiative to create a pan-European Paediatric Clinical Trials Network.